HONG KONG – China continues to roll out reforms for the pharmaceutical industry, the latest of which is a set of improvements to clinical trial regulations. Read More

KARACHI, Pakistan – Facing a chronic lack of regulation, the pharmaceutical industry in Pakistan is struggling to put in place a free market policy to boost the sector and provide quality drugs to a population of more than 200 million. Read More

At least one of the abstracts highlighted at the press briefing of the American Society of Clinical Oncology (ASCO) last week threw an involuntary highlight on the problems that can beset cancer treatment even in successful trials. Read More

A new Japanese study’s findings cast light on the role of intracellular signaling mediated by reactive oxygen species (ROS) in maintaining placental angiogenesis, which may explain the failure of clinical trials of antioxidants in preeclampsia and supports their use for the currently untreatable condition. Read More

PERTH, Australia – Avita Medical Ltd. plans to submit its Recell spray-on-skin premarket approval application to the FDA in a few weeks following positive results from its pivotal trial. Read More

Sosei Group Corp., of Tokyo, said its subsidiary, Heptares Therapeutics, has been notified by partner Teva Pharmaceutical Industries Ltd., of Petah Tikva, Israel, that a preclinical candidate calcitonin gene-related peptide antagonist has been nominated for advancement into further preclinical studies as an investigational treatment for migraine.  Read More